Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced new long-term data highlighting the sustained survival benefits of KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 ...
Penn Engineers have developed a mathematical "Rosetta Stone" that translates atomic and molecular movements into predictions ...
The Tundra isn't like other Toyota hybrids, chiefly because it's not all that thrifty, and yet you'll still pay far more for ...